Laboratory research demonstrates that BPC-157 treatment accelerates wound healing in diverse injury models including alkali burns, surgical incisions, and chronic wounds, with the peptide enhancing proliferation, migration, and angiogenesis in vitro through dose-dependent ERK1/2 phosphorylation leading to increased cellular proliferation, migration, and vascular tube formation
It has also demonstrated the potential to reduce inflammation, improve gut health, and even accelerate recovery from surgery or injury
Phase 3 (Weeks 3-8) : Both peptides support final repair, reducing scar formation and strengthening repaired tissue
BPC-157 Extensive animal and in-vitro studies on tendon, ligament, and gut tissue
Users tolerate AOD 9604 and CJC 1295 well
Reconstitute the 5 mg vial with 2 mL of bacteriostatic water, swirl gently, and store at 28C, using within 4 weeks